Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2559.2009.03340.x | DOI Listing |
Neth J Med
August 2018
Department of Internal Medicine, Haaglanden Medical Centre, The Hague, the Netherlands.
Hydroxycarbamide is used in the treatment of myeloproliferative neoplasms. Hydroxycarbamide is known for its relative lack of severe side effects. Here we present a 66-year-old man with a severe pneumonitis within three weeks after starting him on hydroxycarbamide.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!